ALENDRONATE SODIUM
NDC 70518-1192, Alendronate sodium, tablet, from REMEDYREPACK INC..
- Product NDC
- 70518-1192
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076768
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-1192 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALENDRONATE SODIUM35 mg/1
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-1192-1 | 70518119201 | 3 BLISTER PACK in 1 CARTON (70518-1192-1) / 4 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c7e470d6-508e-466e-a78d-060bbbc9745c
Use it
Look up 70518-1192 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-1192 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-1192. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.